Health Care & Life Sciences » Pharmaceuticals | Immune Design Corp.

Immune Design Corp.

Immune Design Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
48.16 M
Public Float
35.18 M
Immune Design Corp.
Stock Exchange NASDAQ Stock Market
EPS
$1.38
Market Cap
$163.76 M
Shares Outstanding
48.17 M
Public Float
28.99 M

Profile

Address
1616 Eastlake Avenue East
Seattle Washington 98102
United States
Employees -
Website http://www.immunedesign.com
Updated 09/14/2018
Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G.

Financials

View All

Carlos V. Paya
President, Chief Executive Officer & Director
Ed E. Penhoet
Chairman